Morgan Stanley Keeps Equal-Weight Rating On HMA

Morgan Stanley maintains its Equal-weight rating on Health Management Associates (NYSE: HMA), but looks to service expansions to drive gains for the company.

Says Morgan Stanley in the report, HMA remains very focused on service line expansions, which tend to drive higher margin and higher acuity procedures. HMA highlighted its substantial investments in the DaVinci robot system, as well as in MAKOplasty units as an illustration of its expansion into higher-end services in select communities as means of attracting top physician talent, and gaining market share.”

HMA closed yesterday at $11.14.